DoD Autism, Clinical Trial Award

archived

The ARP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. The FY20 ARP Clinical Trial Award seeks applications from all areas of clinical research. The ARP encourages applications that address critical needs of the ASD community in one or more of the following areas: • Dissemination/implementation of clinically validated interventions • Behavioral, cognitive, and other non-pharmacological therapies for ASD core symptoms or to alleviate co-occurring conditions • Pharmacological, genetic, and other biological treatments for ASD core symptoms or to alleviate co-occurring conditions • Improve diagnosis and access to services across the life span • Interventions promoting success in key transitions to adulthood for individuals living with ASD • Healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the life span and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief) • Cultural, socioeconomic, and gender factors in diagnosis, treatment efficacy, delivery, and access to services • Understanding heterogeneity in treatment response

High